E.coli-derived human EGR2 recombinant protein (Position: M1-R257). Human EGR2 shares 90.7% amino acid (aa) sequence identity with both mouse and rat EGR2.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
E3 SUMO-protein ligase EGR2
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted